Soraya Hölper

Title: Soraya Hölper: Innovator in Antigen-Binding Proteins

Introduction

Soraya Hölper is a prominent inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antigen-binding proteins. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Soraya Hölper holds a patent for "FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptides." This patent provides details on FGFR1/KLB targeting agonistic antigen-binding proteins, or fragments thereof, that possess improved physico-chemical properties. Additionally, the patent includes conjugates that comprise an FGFR1/KLB targeting agonistic antigen-binding protein and at least one GLP-1R agonistic peptide. The patent also discusses pharmaceutical compositions that utilize these antibodies or fragments, highlighting their potential applications in medicine.

Career Highlights

Soraya Hölper is currently employed at Sanofi, a global healthcare company. Her role at Sanofi allows her to collaborate with leading experts in the field and contribute to groundbreaking research and development initiatives.

Collaborations

Some of her notable coworkers include Mark Sommerfeld and Thomas Langer. Their collaboration fosters an environment of innovation and shared knowledge, which is essential for advancing their research projects.

Conclusion

Soraya Hölper is a remarkable inventor whose work in antigen-binding proteins has the potential to impact the medical field significantly. Her contributions, particularly through her patent, demonstrate her commitment to innovation and improving healthcare solutions.